Avandia

Type: Product
Name: Avandia
First reported Aug 28 2014 - Updated Aug 29 2014 - 1 reports

SCV Sheriff's Station Valencia Weekly Crime Breakdown

An assault with a deadly weapon occurred near the 24000 block of Valencia Boulevard, Valencia. A suspect was being detained by loss prevention for shoplifting. Once outside the suspect tried to get away and attacked the victim. The suspect, bite the victim ... [Published Santa Clarita Valley Signal - Aug 28 2014]
First reported Aug 29 2014 - Updated Aug 29 2014 - 1 reports

diaTribe Presents at the FDA – A Public Hearing About the Challenges of CVOTs and Bringing Drugs to Market

Twitter summary: dT presents at @US_FDA on interim results for CVOT trials in #diabetes & why we can’t delay innovationIn 2008, the FDA mandated that companies demonstrate that new diabetes drugs don’t carry an excessive risk of heart disease or strokes ... [Published diaTribe - Aug 29 2014]
First reported Aug 28 2014 - Updated Aug 28 2014 - 1 reports

For drug settlement victim, Coakley is no heroine

Attorney General Martha Coakley says she has opened a hotline for Market Basket employees. I find this to be yet another example of what Coakley will do to try to make herself look good to the voters.I am a victim of the drug Avandia (congestive heart ... [Published Cape Cod Online - Aug 28 2014]
First reported Aug 20 2014 - Updated Aug 20 2014 - 1 reports

GranuFlo/NaturaLyte Case Remanded to State Court By Missouri Federal Judge, Baron and Budd Reports

Judge Rejects Assertion By Defendants that Plaintiffs’ Claims Were Fraudulent A Missouri federal judge has remanded a lawsuit filed by a group of dialysis patients who were treated with GranuFlo and NaturaLyte to the City of St. Louis Circuit Court, reports ... [Published PRWeb - Aug 20 2014]
First reported Aug 11 2014 - Updated Aug 12 2014 - 1 reports

Safety of new drugs questioned by researchers

Dr FrankPhysicians and patients should avoid new drugs unless they are truly breakthrough drugs, according to a study in Health Affairs .“FDA needs to make sure drugs are safe before they're approved and not rush to judgment in order to meet artificial ... [Published Formulary Journal - Aug 11 2014]
First reported Aug 08 2014 - Updated Aug 08 2014 - 1 reports

Novo says Tresiba trial is ahead of schedule

Novo Nordisk A/S said that a cardiovascular outcomes study for one of its newest products, Tresiba, is proceeding ahead of schedule, raising the prospect that data could be submitted to the Food and Drug Administration in the first half of 2015 with a ... [Published MedNous - Aug 08 2014]
Entities: Tresiba, Insulin, Victoza
First reported Aug 08 2014 - Updated Aug 08 2014 - 1 reports

FDA lifts restrictions on patient access to Avandia

The type 2 - diabetes drug Avandia will again be available through retail pharmacies after a May ruling by the U.S. Food and Drug Administration.The drug - a rosiglitazone-based medicine that controls blood glucose by increased the body’s sensitivity ... [Published Diabetes Health Magazine - Aug 08 2014]
First reported Aug 05 2014 - Updated Aug 05 2014 - 1 reports

Five Sangamo Scientists Recognized By Thomson Reuters Among Most Highly Cited Researchers Worldwide Of 2014

(Date:8/5/2014)... , Aug. 5, 2014 ... report is available in its catalogue: ... to 2020 http://www.reportlinker.com/p02243686/Australia-Endoscopy-Visualization-Systems-Market-Outlook-to-2020.html ... Market Outlook to 2020 Summary ... Market ... [Published Bio-Medicine - Aug 05 2014]
First reported Jul 29 2014 - Updated Jul 29 2014 - 1 reports

Should Dr. Oz be Silenced?

Mehmet Oz – World Economic Forum Annual Meeting 2012 – Source: WikimediaMedical Student Launches Campaign Against Dr. Ozby Alliance for Natural HealthAs his popularity with Americans grows—and with it a new openness to integrative medicine—mainstream ... [Published Health Impact News - Jul 29 2014]
First reported Jul 24 2014 - Updated Jul 24 2014 - 1 reports

What Do We Want Out of Our Diabetes Treatments?

We want our diabetes treatments to be effective, but we also want them to be safe, and it is up to the FDA to decide if the benefits of a given medication outweigh the risks. Consider insulin: if misused, it can kill you, but its benefits – it keeps all ... [Published diaTribe - Jul 24 2014]
First reported Jun 16 2014 - Updated Jun 16 2014 - 1 reports

Baron and Budd reaches $177m settlement for seven states against GlaxoSmithKline

The national law firm of Baron and Budd has reached a $177 million settlement with GlaxoSmithKline on behalf of the states of Kentucky, Maryland, Mississippi, New Mexico, South Carolina, Utah and West Virginia regarding the deceptive advertising of the ... [Published Pharmaceutical Business Review - Jun 16 2014]
First reported Jun 13 2014 - Updated Jun 13 2014 - 6 reports

Baron and Budd Announces $177 Million Settlement for Seven States Against Avandia Manufacturer GlaxoSmithKline

DALLAS, Jun 13, 2014 (BUSINESS WIRE) -- The national law firm of Baron and Budd has reached a $177 million settlement with GlaxoSmithKline on behalf of the states of Kentucky, Maryland, Mississippi, New Mexico, South Carolina, Utah and West Virginia regarding ... [Published PharmaGossip - Jun 13 2014]

Quotes

"There are clear warning signs about these scams, which continue at high levels throughout the nation,” said IRS Commissioner John Koskinen. “Taxpayers should remember their first contact with the IRS will not be a call from out of the blue, but through official correspondence sent through the mail. A big redred flag for these scams are angry, threatening calls from people who say they are from the IRS and urging immediate payment. This is not how we operate. People should hang up immediately and contact TIGTA or the IRS.”"
...As a result the cases now being filed are increasing everyday." As is with most mass tort cases, "there also remains a chance that some plaintiffs will not receive any compensation whatsoever" the company added
...No drug is truly safe or risk free," Phillips said. "In the context of diabetes care, weight management, diet, and exercise may limit your need for any of these medications."
...is really about the increasing total cost of specialty medications, considering both cost and prevalence of treatment targets," the authors said. "While a daily oral medication that costs $1,000 per pill gains attention, the more important issue is the number of people eligible for treatment. Sofosbuvir is not really a per-unit cost outlier, but is a 'total cost' outlier because of its high cost and very large population eligible for treatment -- a beacon for costs of specialty medications generally."

More Content

All (47) | News (32) | Reports (0) | Blogs (15) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
diaTribe Presents at the FDA – A Public Hearing... [Published diaTribe - Aug 29 2014]
SCV Sheriff's Station Valencia Weekly Crime Bre... [Published Santa Clarita Valley Signal - Aug 28 2014]
For drug settlement victim, Coakley is no heroine [Published Cape Cod Online - Aug 28 2014]
Dreaming The Impossible Dream [Published Drug and Device Law - Aug 22 2014]
GranuFlo/NaturaLyte Case Remanded to State Cour... [Published PRWeb - Aug 20 2014]
Dianne M. Nast Appointed to General Motors Liti... [Published Crawford Financial Planning - Aug 19 2014]
Lawsuit Settlement News Website Reports Update ... [Published TickerTech.com - Aug 15 2014]
Rosiglitazone REMS Restrictions Removed [Published ASHP - Aug 14 2014]
News in Brief: Week of Aug. 4-8 [Published American Family Physician - Aug 12 2014]
Ebola vaccine to be manufactured by criminal dr... [Published Natural News - Aug 11 2014]
Safety of new drugs questioned by researchers [Published Formulary Journal - Aug 11 2014]
Novo says Tresiba trial is ahead of schedule [Published MedNous - Aug 08 2014]
FDA lifts restrictions on patient access to Ava... [Published Diabetes Health Magazine - Aug 08 2014]
Five Sangamo Scientists Recognized By Thomson R... [Published Bio-Medicine - Aug 05 2014]
Texas Transvaginal Mesh Recipients Press State’... [Published PRWeb - Aug 03 2014]
Should Dr. Oz be Silenced? [Published Health Impact News - Jul 29 2014]
People with more brown fat better able to contr... [Published Diabetes.co.uk - Jul 24 2014]
What Do We Want Out of Our Diabetes Treatments? [Published diaTribe - Jul 24 2014]
Safety profile of blockbuster blood thinner com... [Published Los Angeles Times - Jul 24 2014]
Attorney Bryan Schefman Wins in US Court of App... [Published PRWeb - Jul 18 2014]
Status Conference Regarding Risperdal Litigatio... [Published PRWeb - Jul 08 2014]
GlaxoSmithKline to Pay $105 Million to Settle C... [Published PRWeb - Jun 27 2014]
FDA orders GlaxoSmithKline to review manufactur... [Published Guardian.co.uk - Jun 24 2014]
New Order Issued, Paving the Way for Federal Li... [Published PRWeb - Jun 23 2014]
More Than 1,700 GranuFlo Cases Filed in Federal... [Published PRWeb - Jun 21 2014]
Status Conference on GranuFlo Lawsuits Held, Ba... [Published PRWeb - Jun 18 2014]
Baron and Budd reaches $177m settlement for sev... [Published Pharmaceutical Business Review - Jun 16 2014]
Baron and Budd Announces $177 Million Settlemen... [Published PharmaGossip - Jun 13 2014]
Baron and Budd Announces $177 Million Settlemen... [Published EON Business - Jun 13 2014]
Baron and Budd Announces $177 Million Settlemen... [Published Business Wire Photo/Multimedia News - Jun 13 2014]
1 2
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Dreaming The Impossible Dream [Published Drug and Device Law - Aug 22 2014]
A short history of recent implied preemption “impossibility” decisions:  (1) In Wyeth v. Levine, 555 U.S. 555 (2009), impossibility preemption did not apply to innovator prescription drugs because simultaneous compliance with FDA and state tort law labeling ...
Baron and Budd Announces $177 Million Settlemen... [Published PharmaGossip - Jun 13 2014]
DALLAS, Jun 13, 2014 (BUSINESS WIRE) -- The national law firm of Baron and Budd has reached a $177 million settlement with GlaxoSmithKline on behalf of the states of Kentucky, Maryland, Mississippi, New Mexico, South Carolina, Utah and West Virginia regarding ...
Baron and Budd Announces $177 Million Settlemen... [Published EON Business - Jun 13 2014]
DALLAS--(EON: Enhanced Online News)--The national law firm of Baron and Budd has reached a $177 million settlement with GlaxoSmithKline on behalf of seven states. ...
Baron and Budd Announces $177 Million Settlemen... [Published Business Wire Photo/Multimedia News - Jun 13 2014]
DALLAS--(BUSINESS WIRE)--The national law firm of Baron and Budd has reached a $177 million settlement with GlaxoSmithKline on behalf of seven states. ...
Baron and Budd Announces $177 Million Settlemen... [Published Business Wire Professional Services News - Jun 13 2014]
DALLAS--(BUSINESS WIRE)--The national law firm of Baron and Budd has reached a $177 million settlement with GlaxoSmithKline on behalf of seven states. ...
1 2 3
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.